[1]
|
Manchester, L.C., Poeggeler, B., Alvares, F.L., Ogden, G.B. and Reiter, R.J. (1995) Melatonin Immunoreactivity in the Photosynthetic Prokaryote Rhodospirillum rubrum: Implications for an Ancient Antioxidant System. Cellular and Molecular Biology Research, 41, 391-395.
|
[2]
|
Suofu, Y., et al. (2017) Dual Role of Mitochondria in Producing Melatonin and Driving GPCR Signaling to Block Cytochrome c Release. Proceedings of the National Academy of Sciences, 114, E7997-E8006. https://doi.org/10.1073/pnas.1705768114
|
[3]
|
Venegas, C., et al. (2012) Extrapineal Melatonin: Analysis of Its Subcellular Distribution and Daily Fluctuations. Journal of Pineal Research, 52, 217-227.
https://doi.org/10.1111/j.1600-079X.2011.00931.x
|
[4]
|
Auld, F., Maschauer, E.L., Morrison, I., Skene, D.J. and Riha, R.L. (2017) Evidence for the Efficacy of Melatonin in the Treatment of Primary Adult Sleep Disorders. Sleep Medicine Reviews, 34, 10-22. https://doi.org/10.1016/j.smrv.2016.06.005
|
[5]
|
Karasek, M. (2004) Melatonin, Human Aging, and Age-Related Diseases. Experimental Gerontology, 39, 1723-1729. https://doi.org/10.1016/j.exger.2004.04.012
|
[6]
|
Buscemi, N. (2004) Melatonin for treatment of sleep disorders. Agency for Healthcare Research and Quality.
|
[7]
|
Matheson, E. and Hainer, B.L. (2017) Insomnia: Pharmacologic Therapy. American Family Physician, 96, 29-35.
|
[8]
|
A and C Black (2008) British National Formulary.
|
[9]
|
(2005) Melatonin. Alternative Medicine Review, 10, 326-336.
|
[10]
|
Escames, G., et al. (2010) The Role of Mitochondria in Brain Aging and the Effects of Melatonin. Current Neuropharmacology, 8, 182-193.
https://doi.org/10.2174/157015910792246245
|
[11]
|
Malhotra, S., Sawhney, G. and Pandhi, P. (2004) The Therapeutic Potential of Melatonin: A Review of the Science. Medscape General Medicine, 6, 46.
|
[12]
|
Saumen Kumar, M. and Sourav, E. (2015) Gut Melatonin in Vertebrates: Chronobiology and Physiology. Frontiers in Endocrinology (Lausanne), 6, 112.
https://doi.org/10.3389/fendo.2015.00112
|
[13]
|
Tosini, G., Ferguson, I. and Tsubota, K. (2016) Effects of Blue Light on the Circadian System and Eye Physiology. Molecular Vision, 22, 61-72.
|
[14]
|
Scheer, F.A.J.L. and Czeisler, C.A. (2005) Melatonin, Sleep, and Circadian Rhythms. Sleep Medicine Reviews, 9, 5-9. https://doi.org/10.1016/j.smrv.2004.11.004
|
[15]
|
Reiter, R.J., Paredes, S.D., Korkmaz, A., Jou, M.-J. and Tan, D.-X. (2008) Melatonin Combats Molecular Terrorism at the Mitochondrial Level. Interdisciplinary Toxicology, 1, 137-149. https://doi.org/10.2478/v10102-010-0030-2
|
[16]
|
Li, Y., et al. (2017) Melatonin for the Prevention and Treatment of Cancer. Oncotarget, 8, 39896-39921. https://doi.org/10.18632/oncotarget.16379
|
[17]
|
Xie, W., et al. (2017) Melatonin Potentiates “Inside-Out” Nano-Thermotherapy in Human Breast Cancer Cells: A Potential Cancer Target Multimodality Treatment Based on Melatonin-Loaded Nanocomposite Particles. International Journal of Nanomedicine, 12, 7351-7363. https://doi.org/10.2147/IJN.S148520
|
[18]
|
Shiu, S.Y.W. (2007) Towards Rational and Evidence-Based Use of Melatonin in Prostate Cancer Prevention and Treatment. Journal of Pineal Research, 43, 1-9.
https://doi.org/10.1111/j.1600-079X.2007.00451.x
|
[19]
|
Wei, X., et al. (2018) Hyperbaric Oxygen Treatment Sensitizes Gastric Cancer Cells to Melatonin-Induced Apoptosis through Multiple Pathways. Journal of Cellular Biochemistry, 119, 6723-6731. https://doi.org/10.1002/jcb.26864
|
[20]
|
Kvietkauskas, M., et al. (2020) The Role of Melatonin in Colorectal Cancer Treatment: A Comprehensive Review. Therapeutic Advances in Medical Oncology, 12, 1758835920931714. https://doi.org/10.1177/1758835920931714
|
[21]
|
Yang, Y.-C., et al. (2019) Melatonin Reduces Lung Cancer Stemness through Inhibiting of PLC, ERK, p38, β-Catenin, and Twist Pathways. Environmental Toxicology, 34, 203-209. https://doi.org/10.1002/tox.22674
|
[22]
|
Comai, S., Ochoa-Sanchez, R. and Gobbi, G. (2013) Sleep-Wake Characterization of Double MT1/MT2 Receptor Knockout Mice and Comparison with MT1 and MT2 Receptor Knockout Mice. Behavioural Brain Research, 243, 231-238.
https://doi.org/10.1016/j.bbr.2013.01.008
|
[23]
|
Carrillo-Vico, A., Lardone, P.J., Alvarez-Sánchez, N., Rodríguez-Rodríguez, A. and Guerrero, J.M. (2013) Melatonin: Buffering the Immune System. International Journal of Molecular Sciences, 14, 8638-8683. https://doi.org/10.3390/ijms14048638
|
[24]
|
Foulkes, N.S., Assone-Corsi, P., Borjigin, J. and Snyder, S.H. (1997) Rhythmic Transcription: The Molecular Basis of Circadian Melatonin Synthesis. Trends in Neurosciences, 20, 487-492. https://doi.org/10.1016/S0166-2236(97)01109-0
|
[25]
|
Kamal, M., et al. (2015) Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers. The Journal of Biological Chemistry, 290, 11537-11546. https://doi.org/10.1074/jbc.M114.559542
|
[26]
|
Christian De, B., et al. (2010) Agomelatine, the First Melatonergic Antidepressant: Discovery, Characterization and Development. Nature Reviews Drug Discovery, 9, 628. https://doi.org/10.1038/nrd3140
|
[27]
|
Stauch, B., et al. (2019) Structural Basis of Ligand Recognition at the Human MT1 Melatonin Receptor. Nature (London), 569, 284-288.
https://doi.org/10.1038/s41586-019-1141-3
|
[28]
|
Johansson, L.C., et al. (2019) XFEL Structures of the Human MT2 Melatonin Receptor Reveal the Basis of Subtype Selectivity. Nature (London), 569, 289-292.
https://doi.org/10.1038/s41586-019-1144-0
|
[29]
|
Murray, C.J. and Lopez, A.D. (1997) Alternative Projections of Mortality and Disability by Cause 1990-2020: Global Burden of Disease Study. The Lancet (London, England), 349, 1498-1504. https://doi.org/10.1016/S0140-6736(96)07492-2
|
[30]
|
Golan, D., et al. (2013) The Influence of Vitamin D Supplementation on Melatonin Status in Patients with Multiple Sclerosis. Brain, Behavior, and Immunity, 32, 180-185. https://doi.org/10.1016/j.bbi.2013.04.010
|
[31]
|
Williams, J.W., et al. (2000) A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary. Annals of Internal Medicine, 132, 743-756. https://doi.org/10.7326/0003-4819-132-9-200005020-00011
|
[32]
|
Anderson, I.M. and Tomenson, B.M. (1995) Treatment Discontinuation with Selective Serotonin Reuptake Inhibitors Compared with Tricyclic Antidepressants: A Meta-Analysis. BMJ: British Medical Journal, 310, 1433.
https://doi.org/10.1136/bmj.310.6992.1433
|
[33]
|
Overstreet, H.D., Pucilowski, H.O., Retton, H.M.-C., Delagrange, H.P. and Guardiola-Lemaitre, H.B. (1998) Effects of Melatonin Receptor Ligands on Swim Test Immobility. NeuroReport, 9, 249-253.
https://doi.org/10.1097/00001756-199801260-00014
|
[34]
|
Micale, V., Arezzi, A., Rampello, L. and Drago, F. (2006) Melatonin Affects the Immobility Time of Rats in the Forced Swim Test: The Role of Serotonin Neurotransmission. European Neuropsychopharmacology, 16, 538-545.
https://doi.org/10.1016/j.euroneuro.2006.01.005
|
[35]
|
Pévet, P. (2016) Melatonin Receptors as Therapeutic Targets in the Suprachiasmatic Nucleus. Expert Opinion on Therapeutic Targets, 20, 1209-1218.
https://doi.org/10.1080/14728222.2016.1179284
|
[36]
|
Esposito, E. and Cuzzocrea, S. (2010) Antiinflammatory Activity of Melatonin in Central Nervous System. Current Neuropharmacology, 8, 228-242.
https://doi.org/10.2174/157015910792246155
|
[37]
|
Mohan, N., Sadeghi, K., Reiter, R.J. and Meltz, M.L. (1995) The Neurohormone Melatonin Inhibits Cytokine, Mitogen and Ionizing Radiation Induced NF-kappa B. Biochemistry and Molecular Biology International, 37, 1063-1070.
|
[38]
|
Calvo, J.R., González-Yanes, C. and Maldonado, M.D. (2013) The Role of Melatonin in the Cells of the Innate Immunity: A Review. Journal of Pineal Research, 55, 103-120. https://doi.org/10.1111/jpi.12075
|
[39]
|
Carrillo-Vico, A., Guerrero, J., Lardone, P. and Reiter, R. (2005) A Review of the Multiple Actions of Melatonin on the Immune System. Endocrine, 27, 189-200.
https://doi.org/10.1385/ENDO:27:2:189
|
[40]
|
Molinero, P., Soutto, M., Benot, S., Hmadcha, A. and Guerrero, J.M. (2000) Melatonin Is Responsible for the Nocturnal Increase Observed in Serum and Thymus of Thymosin Alpha1 and Thymulin Concentrations: Observations in Rats and Humans. Journal of Neuroimmunology, 103, 180-188.
https://doi.org/10.1016/S0165-5728(99)00237-4
|
[41]
|
Luchetti, F., et al. (2006) Melatonin Prevents Apoptosis Induced by UV-B Treatment in U937 Cell Line. Journal of Pineal Research, 40, 158-167.
https://doi.org/10.1111/j.1600-079X.2005.00293.x
|
[42]
|
Pedrosa, A.M., et al. (2010) Melatonin Protects CD4+ T Cells from Activation-Induced Cell Death by Blocking NFAT-Mediated CD95 Ligand Upregulation. The Journal of Immunology, 184, 3487-3494. https://doi.org/10.4049/jimmunol.0902961
|
[43]
|
Sánchez-Barceló, E.J., Mediavilla, M.D., Tan, D.X. and Reiter, R.J. (2010) Clinical Uses of Melatonin: Evaluation of Human Trials. Current Medicinal Chemistry, 17, 2070-2095. https://doi.org/10.2174/092986710791233689
|
[44]
|
Cos, S. and Sánchez-Barceló, E.J. (1994) Differences between Pulsatile or Continuous Exposure to Melatonin on MCF-7 Human Breast Cancer Cell Proliferation. Cancer Letters, 85, 105-109. https://doi.org/10.1016/0304-3835(94)90245-3
|
[45]
|
Lissoni, P., et al. (1995) Modulation of Cancer Endocrine Therapy by Melatonin: A Phase II Study of Tamoxifen plus Melatonin in Metastatic Breast Cancer Patients Progressing under Tamoxifen Alone. British Journal of Cancer, 71, 854.
https://doi.org/10.1038/bjc.1995.164
|
[46]
|
Neri, B., et al. (1994) Modulation of Human Lymphoblastoid Interferon Activity by Melatonin in Metastatic Renal Cell Carcinoma. A Phase II Study. Cancer, 73, 3015-3019.
https://doi.org/10.1002/1097-0142(19940615)73:12<3015::AID-CNCR2820731220>3.0.CO;2-N
|
[47]
|
Lissoni, P., et al. (1992) Randomized Study with the Pineal Hormone Melatonin versus Supportive Care Alone in Advanced Nonsmall Cell Lung Cancer Resistant to a First-Line Chemotherapy Containing Cisplatin. Oncology, 49, 336-339.
https://doi.org/10.1159/000227068
|
[48]
|
Aldeghi, R., et al. (1994) Low-Dose Interleukin-2 Subcutaneous Immunotherapy in Association with the Pineal Hormone Melatonin as a First-Line Therapy in Locally Advanced or Metastatic Hepatocellular-Carcinoma. European Journal of Cancer, 30, 167-170. https://doi.org/10.1016/0959-8049(94)90080-9
|
[49]
|
Lissoni, P., et al. (1994) A Randomized Study with the Pineal Hormone Melatonin versus Supportive Care Alone in Patients with Brain Metastases Due to Solid Neoplasms. Cancer, 73, 699-701.
https://doi.org/10.1002/1097-0142(19940201)73:3<699::AID-CNCR2820730332>3.0.CO;2-L
|
[50]
|
González-González, A., et al. (2020) Usefulness of Melatonin as Complementary to Chemotherapeutic Agents at Different Stages of the Angiogenic Process. Scientific Reports, 10, Article No. 4790. https://doi.org/10.1038/s41598-020-61622-x
|
[51]
|
Russo, I. and Russo, J. (1998) Role of Hormones in Mammary Cancer Initiation and Progression. Journal of Mammary Gland Biology and Neoplasia, 3, 49-61.
https://doi.org/10.1023/A:1018770218022
|
[52]
|
Cohen, M., Lippman, M. and Chabner, B. (1978) Role of Pineal Gland in Aetiology and Treatment of Breast Cancer. The Lancet (London, England), 2, 814-816.
https://doi.org/10.1016/S0140-6736(78)92591-6
|
[53]
|
Blask, D., et al. (1991) Pineal Melatonin Inhibition of Tumor Promotion in the N-nitroso-N-methylurea Model of Mammary Carcinogenesis: Potential Involvement of Antiestrogenic Mechanisms in Vivo. Journal of Cancer Research and Clinical Oncology, 117, 526-532. https://doi.org/10.1007/BF01613283
|
[54]
|
American Cancer Society (2020) Cancer Facts and Figures.
https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf
|
[55]
|
Pariente, R., Bejarano, I., Rodríguez, A.B., Pariente, J.A. and Espino, J. (2018) Melatonin Increases the Effect of 5-Fluorouracil-Based Chemotherapy in Human Colorectal Adenocarcinoma Cells in Vitro. Molecular and Cellular Biochemistry, 440, 43-51. https://doi.org/10.1007/s11010-017-3154-2
|
[56]
|
Conant, K. and Gottschall, P. (2005) Matrix Metalloproteinases in the Central Nervous System. Imperial College Press.
|
[57]
|
Pal, S., Ganguly, K.K. and Chatterjee, A. (2013) Extracellular Matrix Protein Fibronectin Induces Matrix Metalloproteinases in Human Prostate Adenocarcinoma Cells PC-3. Cell Communication and Adhesion, 20, 105-114.
https://doi.org/10.3109/15419061.2013.833193
|
[58]
|
Fridman, R., Toth, M., Chvyrkova, I., Meroueh, S. and Mobashery, S. (2003) Cell Surface Association of Matrix Metalloproteinase-9 (Gelatinase B). Cancer and Metastasis Reviews, 22, 153-166. https://doi.org/10.1023/A:1023091214123
|
[59]
|
Ramos-Desimone, N., et al. (1999) Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion. Journal of Biological Chemistry, 274, 13066-13076.
https://doi.org/10.1074/jbc.274.19.13066
|
[60]
|
Vu, T.H., et al. (1998) MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes. Cell, 93, 411-422.
https://doi.org/10.1016/S0092-8674(00)81169-1
|
[61]
|
Johnson, M.C., Sung, E.H.-J., Lessner, S.S., Fini, S.M. and Galis, S.Z. (2004) Matrix Metalloproteinase-9 Is Required for Adequate Angiogenic Revascularization of Ischemic Tissues: Potential Role in Capillary Branching. Circulation Research: Journal of the American Heart Association, 94, 262-268.
https://doi.org/10.1161/01.RES.0000111527.42357.62
|
[62]
|
Larsen, P.H., Wells, J.E., Stallcup, W.B., Opdenakker, G. and Yong, V.W. (2003) Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23, 11127-11135.
https://doi.org/10.1523/JNEUROSCI.23-35-11127.2003
|
[63]
|
Ram, M., Sherer, Y. and Shoenfeld, Y. (2006) Matrix Metalloproteinase-9 and Autoimmune Diseases. Journal of Clinical Immunology, 26, 299-307.
https://doi.org/10.1007/s10875-006-9022-6
|
[64]
|
Rohde, L.E., et al. (1999) Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement after Experimental Myocardial Infarction in Mice. Circulation, 99, 3063-3070. https://doi.org/10.1161/01.CIR.99.23.3063
|
[65]
|
Sellner, J. and Leib, S.L. (2006) In Bacterial Meningitis Cortical Brain Damage Is Associated with Changes in Parenchymal MMP-9/TIMP-1 Ratio and Increased Collagen Type IV Degradation. Neurobiology of Disease, 21, 647-656.
https://doi.org/10.1016/j.nbd.2005.09.007
|
[66]
|
Starckx, S., Van Den Steen, P.E., Verbeek, R., van Noort, J.M. and Opdenakker, G. (2003) A Novel Rationale for Inhibition of Gelatinase B in Multiple Sclerosis: MMP-9 Destroys αB-Crystallin and Generates a Promiscuous T Cell Epitope. Journal of Neuroimmunology, 141, 47-57.
https://doi.org/10.1016/S0165-5728(03)00217-0
|
[67]
|
Vandooren, J., Van den Steen, P.E. and Opdenakker, G. (2013) Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9): The Next Decade. Critical Reviews in Biochemistry and Molecular Biology, 48, 222-272.
https://doi.org/10.3109/10409238.2013.770819
|
[68]
|
Egeblad, M. and Werb, Z. (2002) New Functions for the Matrix Metalloproteinases in Cancer Progression. Nature Reviews Cancer, 2, 161-174.
https://doi.org/10.1038/nrc745
|
[69]
|
Iurlaro, et al. (1999) Angiogenesis Extent and Expression of Matrix Metalloproteinase-2 and -9 Correlate with Upgrading and Myometrial Invasion in Endometrial Carcinoma. European Journal of Clinical Investigation, 29, 793-801.
https://doi.org/10.1046/j.1365-2362.1999.00532.x
|
[70]
|
Bergers, G., et al. (2000) Matrix Metalloproteinase-9 Triggers the Angiogenic Switch during Carcinogenesis. Nature Cell Biology, 2, 737-744.
https://doi.org/10.1038/35036374
|
[71]
|
Acuff, H.B., Carter, K.J., Fingleton, B., Gorden, D.L. and Matrisian, L.M. (2006) Matrix Metalloproteinase-9 from Bone Marrow-Derived Cells Contributes to Survival But Not Growth of Tumor Cells in the Lung Microenvironment. Cancer Research, 66, 259-266. https://doi.org/10.1158/0008-5472.CAN-05-2502
|
[72]
|
Zucker, S., Lysik, R.M., Zarrabi, M.H. and Moll, U. (1993) M(r) 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer. Cancer Research, 53, 140-146.
|
[73]
|
Tochowicz, A., et al. (2007) Crystal Structures of MMP-9 Complexes with Five Inhibitors: Contribution of the Flexible Arg424 Side-Chain to Selectivity. Journal of Molecular Biology, 371, 989-1006. https://doi.org/10.1016/j.jmb.2007.05.068
|
[74]
|
Ganguly, K., Kundu, P., Banerjee, A., Reiter, R.J. and Swarnakar, S. (2006) Hydrogen Peroxide-Mediated Downregulation of Matrix Metalloprotease-2 in Indomethacin-Induced Acute Gastric Ulceration Is Blocked by Melatonin and Other Antioxidants. Free Radical Biology and Medicine, 41, 911-925.
https://doi.org/10.1016/j.freeradbiomed.2006.04.022
|
[75]
|
Mishra, A., Paul, S. and Swarnakar, S. (2011) Downregulation of Matrix Metalloproteinase-9 by Melatonin during Prevention of Alcohol-Induced Liver Injury in Mice. Biochimie, 93, 854-866. https://doi.org/10.1016/j.biochi.2011.02.007
|
[76]
|
Motilva, V., García-Maurino, S., Talero, E. and Illanes, M. (2011) New Paradigms in Chronic Intestinal Inflammation and Colon Cancer: Role of Melatonin. Journal of Pineal Research, 51, 44-60. https://doi.org/10.1111/j.1600-079X.2011.00915.x
|
[77]
|
Galano, A., Tan, D.X. and Reiter, R.J. (2011) Melatonin as a Natural Ally against Oxidative Stress: A Physicochemical Examination. Journal of Pineal Research, 51, 1-16. https://doi.org/10.1111/j.1600-079X.2011.00916.x
|
[78]
|
Poeggeler, B., et al. (1994) Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of This Indole Accessed in Vitro. Annals of the New York Academy of Sciences, 738, 419-420.
https://doi.org/10.1111/j.1749-6632.1994.tb21831.x
|
[79]
|
Tan, D.-X., et al. (2002) Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scavenger. Current Topics in Medicinal Chemistry, 2, 181-197.
https://doi.org/10.2174/1568026023394443
|
[80]
|
Rudra, D.S., Pal, U., Maiti, N.C., Reiter, R.J. and Swarnakar, S. (2013) Melatonin Inhibits Matrix Metalloproteinase-9 Activity by Binding to Its Active Site. Journal of Pineal Research, 54, 398-405. https://doi.org/10.1111/jpi.12034
|
[81]
|
Cutando, A., Lopez-Valverde, A., Arias-Santiago, S., De Vicente, J. and De Diego, R.G. (2012) Role of Melatonin in Cancer Treatment. AntiCancer Research, 32, 2747-2753.
|
[82]
|
Scheiermann, C., Kunisaki, Y. and Frenette, P.S. (2013) Circadian Control of the Immune System. Nature Reviews Immunology, 13, 190-198.
https://doi.org/10.1038/nri3386
|
[83]
|
Christopher, J.M., Taylor, E.P., Kun, H. and Frank, A.J.L.S. (2016) Circadian Misalignment Increases Cardiovascular Disease Risk Factors in Humans. Proceedings of the National Academy of Sciences, 113, E1402.
https://doi.org/10.1073/pnas.1516953113
|
[84]
|
Jim, H., Tyrer, J., Lin, H., Han, G., Qu, X., Goode, E., Chen, Z., Tsai, Y., Cunningham, J., Iversen, E., Ramus, S., Berchuck, A., Schildkraut, J., Monteiro, A., Gayther, S., Narod, S., Sellers, T., Pharoah, P. and Phelan, C. (2013) Abstract 4850: Variation in Circadian Rhythm Genes Influence Epithelial Ovarian Cancer Risk and Invasiveness. Cancer Research (Chicago, Ill.), 73, 4850.
https://doi.org/10.1158/1538-7445.AM2013-4850
|
[85]
|
Blask, D.E., et al. (2005) Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats. Cancer Research, 65, 11174-11184.
https://doi.org/10.1158/0008-5472.CAN-05-1945
|
[86]
|
Lardone, P.J., Carrillo-Vico, A., Molinero, P., Rubio, A. and Guerrero, J.M. (2009) A Novel Interplay between Membrane and Nuclear Melatonin Receptors in Human Lymphocytes: Significance in IL-2 Production. Cellular and Molecular Life Sciences, 66, 516-525. https://doi.org/10.1007/s00018-008-8601-5
|
[87]
|
Koebel, C.M., et al. (2007) Adaptive Immunity Maintains Occult Cancer in an Equilibrium State. Nature, 450, 903-907. https://doi.org/10.1038/nature06309
|
[88]
|
Knutson, K.L., Disis, M.L. and Salazar, L.G. (2007) CD4 Regulatory T Cells in Human Cancer Pathogenesis. Cancer Immunology, Immunotherapy, 56, 271-285.
https://doi.org/10.1007/s00262-006-0194-y
|
[89]
|
Liu, H., et al. (2011) Role of CD4+ CD25+ Regulatory T Cells in Melatonin-Mediated Inhibition of Murine Gastric Cancer Cell Growth in Vivo and in Vitro. The Anatomical Record (Hoboken), 294, 781-788.
https://doi.org/10.1002/ar.21361
|
[90]
|
Vigoré, L., et al. (2010) Psychoneuroendocrine Modulation of Regulatory T Lymphocyte System: In Vivo and in Vitro Effects of the Pineal Immunomodulating Hormone Melatonin. In Vivo, 24, 787-789.
|
[91]
|
Kawaguchi, K., et al. (2019) Alteration of Specific Cytokine Expression Patterns in Patients with Breast Cancer. Scientific Reports, 9, Article No. 2924.
https://doi.org/10.1038/s41598-019-39476-9
|
[92]
|
Marotta, L.L.C. and Polyak, K. (2011) Unraveling the Complexity of Basal-Like Breast Cancer. Oncotarget, 2, 588-589. https://doi.org/10.18632/oncotarget.314
|
[93]
|
Leek, R.D. and Harris, A.L. (2002) Tumor-Associated Macrophages in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 7, 177-189.
https://doi.org/10.1023/A:1020304003704
|
[94]
|
Lacoste, B., et al. (2015) Anatomical and Cellular Localization of Melatonin MT1 and MT2 Receptors in the Adult Rat Brain. Journal of Pineal Research, 58, 397-417.
https://doi.org/10.1111/jpi.12224
|
[95]
|
Reiter, R.J., et al. (2007) Medical Implications of Melatonin: Receptor-Mediated and Receptor-Independent Actions. Advances in Medical Sciences, 52, 11-28.
|
[96]
|
Slominski, R.M., Reiter, R.J., Schlabritz-Loutsevitch, N., Ostrom, R.S. and Slominski, A.T. (2012) Melatonin Membrane Receptors in Peripheral Tissues: Distribution and Functions. Molecular and Cellular Endocrinology, 351, 152-166.
https://doi.org/10.1016/j.mce.2012.01.004
|
[97]
|
He, B., et al. (2016) The Nuclear Melatonin Receptor RORα Is a Novel Endogenous Defender against Myocardial Ischemia/Reperfusion Injury. Journal of Pineal Research, 60, 313-326. https://doi.org/10.1111/jpi.12312
|
[98]
|
Lardone, P.J., et al. (2011) Melatonin Synthesized by T Lymphocytes as a Ligand of the Retinoic Acid-Related Orphan Receptor. Journal of Pineal Research, 51, 454-462. https://doi.org/10.1111/j.1600-079X.2011.00909.x
|
[99]
|
Becker-André, M., et al. (1994) Pineal Gland Hormone Melatonin Binds and Activates an Orphan of the Nuclear Receptor Superfamily. The Journal of Biological Chemistry, 269, 28531-28534.
|
[100]
|
Pozo, D., et al. (1997) Expression of the Mel1a-Melatonin Receptor mRNA in T and B Subsets of Lymphocytes from Rat Thymus and Spleen. FASEB Journal, 11, 466-473. https://doi.org/10.1096/fasebj.11.6.9194527
|
[101]
|
Gonzalez-Haba, M.G., Garcia-Maurino, S., Calvo, J.R., Goberna, R. and Guerrero, J.M. (1995) High-Affinity Binding of Melatonin by Human Circulating T Lymphocytes (CD4+). FASEB Journal, 9, 1331-1335.
https://doi.org/10.1096/fasebj.9.13.7557023
|
[102]
|
Ren, W., et al. (2017) Melatonin Signaling in T Cells: Functions and Applications. Journal of Pineal Research, 62, e12394. https://doi.org/10.1111/jpi.12394
|
[103]
|
Dempsey, L. (2015) Melatonin Zaps TH17. Nature Immunology, 16, 1113.
https://doi.org/10.1038/ni.3300
|
[104]
|
Knochelmann, H.M., et al. (2018) When Worlds Collide: Th17 and Treg Cells in Cancer and Autoimmunity. Cellular and Molecular Immunology, 15, 458-469.
https://doi.org/10.1038/s41423-018-0004-4
|
[105]
|
Luo, J., et al. (2020) Effect of Melatonin on T/B Cell Activation and Immune Regulation in Pinealectomy Mice. Life Sciences, 242, Article ID: 117191.
https://doi.org/10.1016/j.lfs.2019.117191
|
[106]
|
Mediavilla, M.D., Sanchez-Barcelo, E.J., Tan, D.X., Manchester, L. and Reiter, R.J. (2010) Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin. Current Medicinal Chemistry, 17, 4462-4481.
https://doi.org/10.2174/092986710794183015
|
[107]
|
Casado-Zapico, S., et al. (2010) Synergistic Antitumor Effect of Melatonin with Several Chemotherapeutic Drugs on Human Ewing Sarcoma Cancer Cells: Potentiation of the Extrinsic Apoptotic Pathway. Journal of Pineal Research, 48, 72-80.
https://doi.org/10.1111/j.1600-079X.2009.00727.x
|
[108]
|
Reiter, R.J., Tan, D.X., Sainz, R.M., Mayo, J.C. and Lopez-Burillo, S. (2002) Melatonin: Reducing the Toxicity and Increasing the Efficacy of Drugs. Journal of Pharmacy and Pharmacology, 54, 1299-1321.
https://doi.org/10.1211/002235702760345374
|
[109]
|
Benítez-King, G., Soto-Vega, E. and Ramírez-Rodriguez, G. (2009) Melatonin Modulates Microfilament Phenotypes in Epithelial Cells: Implications for Adhesion and Inhibition of Cancer Cell Migration. Histology and Histopathology, 24, 789-799.
|
[110]
|
Fan, L., Sun, G., Ma, T., Zhong, F. and Wei, W. (2013) Melatonin Overcomes Apoptosis Resistance in Human Hepatocellular Carcinoma by Targeting Survivin and XIAP. Journal of Pineal Research, 55, 174-183.
https://doi.org/10.1111/jpi.12060
|
[111]
|
Cho, C. and Yu, J. (2012) From Inflammation to Cancer: Advances in Diagnosis and Therapy for Gastrointestinal and Hepatological Diseases. In From Inflammation to Cancer. World Scientific Publishing Co. Pte. Ltd.
https://doi.org/10.1142/8117
|
[112]
|
Rauch, D., et al. (2009) Imaging Spontaneous Tumorigenesis: Inflammation Precedes Development of Peripheral NK Tumors. Blood, 113, 1493-1500.
https://doi.org/10.1182/blood-2008-07-166462
|
[113]
|
Zhang, X., et al. (2015) Inflammation-Induced S100A8 Activates Id3 and Promotes Colorectal Tumorigenesis. International Journal of Cancer, 137, 2803-2814.
https://doi.org/10.1002/ijc.29671
|
[114]
|
Urata, Y., et al. (1999) Melatonin Induces γ-Glutamylcysteine Synthetase Mediated by Activator Protein-1 in Human Vascular Endothelial Cells. Free Radical Biology and Medicine, 27, 838-847. https://doi.org/10.1016/S0891-5849(99)00131-8
|
[115]
|
Hey-Mogensen, M., et al. (2010) Effect of Physical Training on Mitochondrial Respiration and Reactive Oxygen Species Release in Skeletal Muscle in Patients with Obesity and Type 2 Diabetes. Diabetologia, 53, 1976.
https://doi.org/10.1007/s00125-010-1813-x
|
[116]
|
Tan, D.-X., et al. (2000) Melatonin Directly Scavenges Hydrogen Peroxide: A Potentially New Metabolic Pathway of Melatonin Biotransformation. Free Radical Biology and Medicine, 29, 1177-1185. https://doi.org/10.1016/S0891-5849(00)00435-4
|
[117]
|
Aydogan, S., Yerer, M.B. and Goktas, A. (2006) Melatonin and Nitric Oxide. Journal of Endocrinological Investigation, 29, 281-287.
https://doi.org/10.1007/BF03345555
|
[118]
|
Munn, E.A. (1974) The Structure of Mitochondria. Elsevier, Amsterdam.
https://doi.org/10.1016/B978-0-12-510150-9.50008-0
|
[119]
|
Acuna-Castroviejo, D., Escames, G., León, J., Carazo, A. and Khaldy, H. (2003) Mitochondrial Regulation by Melatonin and Its Metabolites. Advances in Experimental Medicine and Biology, 527, 549. https://doi.org/10.1007/978-1-4615-0135-0_63
|
[120]
|
Saravanan, K.S., Sindhu, K.M. and Mohanakumar, K.P. (2007) Melatonin Protects against Rotenone-Induced Oxidative Stress in a Hemiparkinsonian Rat Model. Journal of Pineal Research, 42, 247-253.
https://doi.org/10.1111/j.1600-079X.2006.00412.x
|
[121]
|
Stvolinsky, S., Fedorova, N. and Boldyrev, A. (2007) MPTP-Induced Parkinsonian Syndrome in Senescence Accelerated Mice (SAM). Parkinsonism and Related Disorders, 13, S128-S128. https://doi.org/10.1016/S1353-8020(08)70723-5
|
[122]
|
Acuna-Castroviejo, D., Coto-Montes, A., Monti, M.G., Ortiz, G.G. and Reiter, R.J. (1996) Melatonin Is Protective against MPTP-Induced Striatal and Hippocampal Lesions. Life Sciences, 60, PL23-PL29.
https://doi.org/10.1016/S0024-3205(96)00606-6
|
[123]
|
Túnez, I., Montilla, P., Del Carmen Munoz, M., Feijóo, M. and Salcedo, M. (2004) Protective Effect of Melatonin on 3-Nitropropionic Acid-Induced Oxidative Stress in Synaptosomes in an Animal Model of Huntington’s Disease. Journal of Pineal Research, 37, 252-256. https://doi.org/10.1111/j.1600-079X.2004.00163.x
|
[124]
|
Yamamoto, H.-A. and Mohanan, P.V. (2002) Melatonin Attenuates Brain Mitochondria DNA Damage Induced by Potassium Cyanide in Vivo and in Vitro. Toxicology, 179, 29-36. https://doi.org/10.1016/S0300-483X(02)00244-5
|
[125]
|
Yamamoto, H.-A. and Tang, H.-W. (1996) Preventive Effect of Melatonin against Cyanide-Induced Seizures and Lipid Peroxidation in Mice. Neuroscience Letters, 207, 89-92. https://doi.org/10.1016/0304-3940(96)12493-9
|
[126]
|
Floyd, R.A. and Hensley, K. (2002) Oxidative Stress in Brain Aging: Implications for Therapeutics of Neurodegenerative Diseases. Neurobiology of Aging, 23, 795-807.
https://doi.org/10.1016/S0197-4580(02)00019-2
|
[127]
|
Hill, J.M. and Switzer, R.C. (1984) The Regional Distribution and Cellular Localization of Iron in the Rat Brain. Neuroscience, 11, 595-603.
https://doi.org/10.1016/0306-4522(84)90046-0
|
[128]
|
Sanchez-Moreno, C., Dorfman, S., Lichtenstein, A. and Martin, A. (2004) Dietary Fat Type Affects Vitamins C and E and Biomarkers of Oxidative Status in Peripheral and Brain Tissues of Golden Syrian Hamsters. The Journal of Nutrition, 134, 655-660. https://doi.org/10.1093/jn/134.3.655
|
[129]
|
Antolín, I., et al. (1996) Neurohormone Melatonin Prevents Cell Damage: Effect on Gene Expression for Antioxidant Enzymes. FASEB Journal, 10, 882-890.
https://doi.org/10.1096/fasebj.10.8.8666165
|
[130]
|
Rosenbluth, J. (1980) Central Myelin in the Mouse Mutant Shiverer. Journal of Comparative Neurology, 194, 639-648. https://doi.org/10.1002/cne.901940310
|
[131]
|
Hopp, D.C. and Shurtleff, D. (2019) Melatonin: What You Need to Know.
https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know
|
[132]
|
Mayo Clinic Staff (2018) Melatonin.
https://www.mayoclinic.org/drugs-supplements-melatonin/art-20363071
|
[133]
|
(2009) Agomelatine: New Drug. Adverse Effects and No Proven Efficacy. Prescrire International, 18, 241-245.
|
[134]
|
Costello, R., et al. (2014) The Effectiveness of Melatonin for Promoting Healthy Sleep: A Rapid Evidence Assessment of the Literature. Nutrition Journal, 13, 106.
https://doi.org/10.1186/1475-2891-13-106
|
[135]
|
Hardeland, R., et al. (2008) Melatonergic Drugs in Clinical Practice. Arzneimittel-Forschung, 58, 1-10. https://doi.org/10.1055/s-0031-1296459
|
[136]
|
Emet, M., et al. (2016) A Review of Melatonin, Its Receptors and Drugs/Bir Melatonin Derlemesi, Reseptorleri ve Ilaclari. Eurasian Journal of Medicine, 48, 135-141.
https://doi.org/10.5152/eurasianjmed.2015.0267
|
[137]
|
Hardeland, R. (2012) Melatonin in Aging and Disease—Multiple Consequences of Reduced Secretion, Options and Limits of Treatment. Aging and Disease, 3, 194-225.
|
[138]
|
Lin, T.-H., Lai, W.-T. and Sheu, S.-H. (2011) Relationship between Adipokines, Inflammation, Oxidative Stress, Insulin Resistance and Family History of Hypertension in Young-Onset Hypertensives. Journal of the American College of Cardiology, 57, E527. https://doi.org/10.1016/S0735-1097(11)60527-5
|
[139]
|
Paik, J.K., et al. (2012) Circulating and PBMC Lp-PLA 2 Associate Differently with Oxidative Stress and Subclinical Inflammation in Nonobese Women (Menopausal Status) (Lp-PLA 2 Activity, Inflammation and Oxidative Stress). PLoS ONE, 7, e29675. https://doi.org/10.1371/journal.pone.0029675
|
[140]
|
Finelli, M. and Oliver, P. (2017) TLDc Proteins: New Players in the Oxidative Stress Response and Neurological Disease. Mammalian Genome, 28, 395-406.
https://doi.org/10.1007/s00335-017-9706-7
|